Proton irradiation and other charged-particle modalities have demonstr
ated effectiveness in controlling cranial base tumors and other lesion
s. The combination of capabilities available with heavy charged partic
les makes for a desirable therapeutic option that offers the opportuni
ty for tumor ablation while preserving normal tissue function, with ob
vious implications for quality of life.